insights_auto
Why is CHGCY down 4.61%?
Dive Deeperchevron_right
CHGCY:OTCMKTS
Chugai Pharmaceutical ADR
$20.08
arrow_downward
-4.61%(-0.97) 1D
$20.08
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 28, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCY...
Open
$20.04
High
$21.05
Low
$19.94
Mkt. cap
10.24T
Avg. vol.
227.71K
Volume
373.30K
52-wk high
$34.84
52-wk low
$19.94
Beta
0.57
Shares outstanding
3.36B
No. of employees
5K
Open
$20.04
High
$21.05
Low
$19.94
Mkt. cap
10.24T
Avg. vol.
227.71K
Volume
373.30K
52-wk high
$34.84
52-wk low
$19.94
Beta
0.57
Shares outstanding
3.36B
No. of employees
5K
News stories
From web sources and news partners
Investing.com Canada
·
5 hours ago
Why is Chugai Pharmaceutical stock sliding today? By Investing.com
Investing.com
·
6 hours ago
Why is Chugai Pharmaceutical stock sliding today?
TipRanks
·
1 day ago
Chugai Takes Back Rights to Emugrobart as Roche Exits Obesity Program, Revives SMA Focus
Yahoo Finance
·
3 days ago
Chugai Pharmaceutical And 2 Japanese AI Healthcare Stocks To Own
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical ADR
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp